The Neurotropic Properties of AAV-PHP.B Are Limited to C57BL/6J Mice
- PMID: 29428298
- PMCID: PMC5911151
- DOI: 10.1016/j.ymthe.2018.01.018
The Neurotropic Properties of AAV-PHP.B Are Limited to C57BL/6J Mice
Abstract
Improved delivery of adeno-associated virus (AAV) vectors to the CNS will greatly enhance their clinical utility. Selection of AAV9 variants in a mouse model led to the isolation of a capsid called PHP.B, which resulted in remarkable transduction of the CNS following intravenous infusion. However, we now show here that this enhanced CNS tropism is restricted to the model in which it was selected, i.e., a Cre transgenic mouse in a C57BL/6J background, and was not found in nonhuman primates or the other commonly used mouse strain BALB/cJ. We also report the potential for serious acute toxicity in NHP after systemic administration of high dose of AAV.
Copyright © 2018 The American Society of Gene and Cell Therapy. Published by Elsevier Inc. All rights reserved.
Figures



Comment in
-
Safety First: Perspective on Patient-Centered Development of AAV Gene Therapy Products.Mol Ther. 2018 Mar 7;26(3):669-671. doi: 10.1016/j.ymthe.2018.02.009. Epub 2018 Mar 1. Mol Ther. 2018. PMID: 29503193 Free PMC article. No abstract available.
Similar articles
-
Ly6a Differential Expression in Blood-Brain Barrier Is Responsible for Strain Specific Central Nervous System Transduction Profile of AAV-PHP.B.Hum Gene Ther. 2020 Jan;31(1-2):90-102. doi: 10.1089/hum.2019.186. Epub 2019 Dec 13. Hum Gene Ther. 2020. PMID: 31696742
-
AAV-PHP.B Administration Results in a Differential Pattern of CNS Biodistribution in Non-human Primates Compared with Mice.Mol Ther. 2019 Nov 6;27(11):2018-2037. doi: 10.1016/j.ymthe.2019.07.017. Epub 2019 Aug 5. Mol Ther. 2019. PMID: 31420242 Free PMC article.
-
Context-Specific Function of the Engineered Peptide Domain of PHP.B.J Virol. 2021 Sep 27;95(20):e0116421. doi: 10.1128/JVI.01164-21. Epub 2021 Aug 4. J Virol. 2021. PMID: 34346767 Free PMC article.
-
Receptor targeting of adeno-associated virus vectors.Gene Ther. 2003 Jul;10(14):1142-51. doi: 10.1038/sj.gt.3301976. Gene Ther. 2003. PMID: 12833123 Review.
-
Gene therapy for the CNS using AAVs: The impact of systemic delivery by AAV9.J Control Release. 2016 Nov 10;241:94-109. doi: 10.1016/j.jconrel.2016.09.011. Epub 2016 Sep 13. J Control Release. 2016. PMID: 27637390 Review.
Cited by
-
AAV vectors: The Rubik's cube of human gene therapy.Mol Ther. 2022 Dec 7;30(12):3515-3541. doi: 10.1016/j.ymthe.2022.09.015. Epub 2022 Oct 5. Mol Ther. 2022. PMID: 36203359 Free PMC article. Review.
-
Gene therapy using Aβ variants for amyloid reduction.Mol Ther. 2021 Jul 7;29(7):2294-2307. doi: 10.1016/j.ymthe.2021.02.026. Epub 2021 Feb 27. Mol Ther. 2021. PMID: 33647457 Free PMC article.
-
Gene therapy for neurological disorders: progress and prospects.Nat Rev Drug Discov. 2018 Sep;17(9):641-659. doi: 10.1038/nrd.2018.110. Epub 2018 Aug 10. Nat Rev Drug Discov. 2018. PMID: 30093643 Review.
-
Strategy to enhance transgene expression in proximity of amyloid plaques in a mouse model of Alzheimer's disease.Theranostics. 2019 Oct 18;9(26):8127-8137. doi: 10.7150/thno.36718. eCollection 2019. Theranostics. 2019. PMID: 31754385 Free PMC article.
-
LY6S, a New IFN-Inducible Human Member of the Ly6a Subfamily Expressed by Spleen Cells and Associated with Inflammation and Viral Resistance.Immunohorizons. 2022 Apr 19;6(4):253-272. doi: 10.4049/immunohorizons.2200018. Immunohorizons. 2022. PMID: 35440514 Free PMC article.
References
-
- Gao G., Vandenberghe L.H., Wilson J.M. New recombinant serotypes of AAV vectors. Curr. Gene Ther. 2005;5:285–297. - PubMed
-
- Pacak C.A., Mah C.S., Thattaliyath B.D., Conlon T.J., Lewis M.A., Cloutier D.E., Zolotukhin I., Tarantal A.F., Byrne B.J. Recombinant adeno-associated virus serotype 9 leads to preferential cardiac transduction in vivo. Circ. Res. 2006;99:e3–e9. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources